Usana Health Sciences/$USNA
1D1W1MYTD1Y5YMAX
Capital at risk
About Usana Health Sciences
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
- Ticker
- $USNA
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 1,570
- Headquarters
- Salt Lake City, United States
- Website
- www.usana.com
USNA Metrics
BasicAdvanced
$275M
-
-$1.21
0.68
-
Price and volume
Market cap
$275M
Beta
0.68
52-week high
$31.15
52-week low
$12.57
Average daily volume
251K
Financial strength
Current ratio
2.66
Quick ratio
1.627
Interest coverage (TTM)
100.70%
Profitability
EBITDA (TTM)
73.919
Gross margin (TTM)
77.45%
Net profit margin (TTM)
-2.43%
Operating margin (TTM)
4.54%
Effective tax rate (TTM)
1,253.35%
Revenue per employee (TTM)
$580,000
Management effectiveness
Return on assets (TTM)
3.61%
Return on equity (TTM)
-5.06%
Valuation
Price to revenue (TTM)
0.3
Price to book
0.52
Price to tangible book (TTM)
0.94
Price to free cash flow (TTM)
17.174
Free cash flow yield (TTM)
5.82%
Free cash flow per share (TTM)
0.868
Growth
Revenue change (TTM)
1.57%
Earnings per share change (TTM)
-167.19%
3-year revenue growth (CAGR)
-1.23%
10-year revenue growth (CAGR)
-0.55%
3-year earnings per share growth (CAGR)
-28.34%
10-year earnings per share growth (CAGR)
-10.82%
What the Analysts think about USNA
Analyst ratings (Buy, Hold, Sell) for Usana Health Sciences stock.
Analyst projections of the future price of Usana Health Sciences stock.
USNA Financial Performance
Revenues and expenses
USNA Earnings Performance
Company profitability
Upcoming events
No upcoming events
USNA News
AllArticlesVideos
Funds containing USNA
AllEURGBP
Fund name | Fund size | $USNA weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.00% |
Xtrackers S&P 500 Swap£XSPX | £3.1B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.